Significant racial and ethnic differences in uterine fibroid diagnoses have emerged from a large-scale study examining nearly 2 million patients in Northern California’s Kaiser Permanente health system over 13 years. The research reveals that health disparities extend across multiple communities in ways previously underexplored.
Black patients showed the most dramatic disparity, with diagnosis rates more than three times higher than non-Hispanic White patients. Among Asian populations, the variations were notable: South Asian patients had 71% higher rates, East Asians 47% higher, and Southeast Asians 29% higher compared to White patients. Hispanic patients demonstrated a 37% increase in diagnoses.
The study uncovered an intriguing pattern regarding symptom documentation. Asian patients were less likely than other groups to have symptoms recorded in their medical records before receiving a fibroid diagnosis. This raises important questions about whether differences exist in how symptoms present, how they’re documented by healthcare providers, or how patients engage with the healthcare system.
Researchers emphasized that their findings “highlight the need to better understand ethnic-specific risk factors and barriers to care.” They particularly stressed that the variability among Asian subgroups demonstrates why broad racial categories in medical research can obscure important health patterns.
The study stopped short of determining whether these diagnosis rates reflect actual differences in disease prevalence or variations in healthcare access and recognition. However, the findings underscore the critical need for equitable screening practices and culturally sensitive approaches to patient care across diverse communities.
See: “Study Finds Uterine Fibroid Diagnosis Rates Vary by Ethnicity” (7 Apr 2025)
